Membranous nephropathy in children: Clinical presentation and therapeutic approach

Pediatric Nephrology

Volumn 25, Issue 8, 2010, Pages 1419-1428

  Menon, Shina ^a   Valentini, Rudolph P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclophosphamide; Cyclosporine; Membranous glomerulonephritis; Membranous glomerulopathy; Nephrotic syndrome; Pediatrics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CAPTOPRIL; CHLORAMBUCIL; CLOPIDOGREL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GOLD; MERCURY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; ANTIHYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; GINGIVA HYPERPLASIA; HEMATURIA; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; RELAPSE; REVIEW; UNSPECIFIED SIDE EFFECT; UREMIA; BIOPSY; COMPLICATION; GLOMERULONEPHRITIS, MEMBRANOUS; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIOPSY; CHILD; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; NEPHROTIC SYNDROME; PROTEINURIA; STEROIDS; TREATMENT OUTCOME;

EID: 77954424255     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1324-5     Document Type: Review

References (57)

1. JS Cameron 1990 Membranous nephropathy in childhood and its treatment Pediatr Nephrol 4 193 198 10.1007/BF00858840 1:STN:280:DyaK3czntlKltQ%3D%3D 2204413
2. RP Valentini TK Mattoo G Kapur A Imam 2009 Membranous glomerulonephritis: treatment response and outcome in children Pediatr Nephrol 24 301 308 10.1007/s00467-008-1005-9 18846392
3. G Filler E Young P Geier B Carpenter A Drukker J Feber 2003 Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42 1107 1113 10.1053/j.ajkd.2003.08.010 14655180 (Pubitemid 37486752)
4. A Chen R Frank S Vento V Crosby M Chandra B Gauthier E Valderrama H Trachtman 2007 Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome BMC Nephrol 8 11 10.1186/1471-2369-8-11 17683621 (Pubitemid 47346832)
5. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159-165
6. C Kleinknecht M Levy MF Gagnadoux R Habib 1979 Membranous glomerulonephritis with extra-renal disorders in children Medicine (Baltimore) 58 219 228 1:STN:280:DyaE1M7pvVyrtw%3D%3D (Pubitemid 9185647)
7. C Ponticelli 2007 Membranous nephropathy J Nephrol 20 268 287 1:CAS:528:DC%2BD2sXhsVKgt7jN 17557260
8. Y Kawasaki J Suzuki N Onishi A Takahashi M Isome H Suzuki 2005 IgA deficiency and membranous glomerulonephritis presenting as nephrotic syndrome Pediatr Nephrol 20 662 664 10.1007/s00467-004-1720-9 15711951 (Pubitemid 41166624)
9. B Ivanyi I Haszon E Endreffy P Szenohradszky IB Petri T Kalmar RJ Butkowski AS Charonis S Turi 1998 Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: an 11-year follow-up Am J Kidney Dis 32 1068 1074 10.1016/S0272-6386(98)70085-X 1:STN:280:DyaK1M%2Fnt1entA%3D%3D 9856526
10. RJ Glassock 1992 Secondary membranous glomerulonephritis Nephrol Dial Transplant 7 Suppl 1 64 71 1337185
11. MM Moxey-Mims FB Stapleton LG Feld 1994 Applying decision analysis to management of adolescent idiopathic nephrotic syndrome Pediatr Nephrol 8 660 664 10.1007/BF00869080 1:STN:280:DyaK2M3htVSrsg%3D%3D 7696099
12. H Olbing I Greifer BP Bennett J Bernstein A Spitzer 1973 Idiopathic membranous nephropathy in children Kidney Int 3 381 390 10.1038/ki.1973.60 1:STN:280:DyaE2c7nt1Oisw%3D%3D 4791142
13. BH Lee HY Cho HG Kang IS Ha HI Cheong KC Moon IS Lim Y Choy 2006 Idiopathic membranous nephropathy in children Pediatr Nephrol 21 1707 1715 10.1007/s00467-006-0246-8 16951933 (Pubitemid 44390837)
14. WC Chan YC Tsao 1966 Diffuse membranous glomerulonephritis in children J Clin Pathol 19 464 469 10.1136/jcp.19.5.464 1:STN:280:DyaF2s%2FhslOqug%3D%3D 4958475
15. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) (2007) Annual Report. Available at www.naprtcs.org. Accessed July 12, 2008
16. U.S. Renal Data System (2008) Atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. In: USRDS 2008 Annual Data Report, Bethesda MD, 2008
17. FC Fervenza S Sethi U Specks 2008 Idiopathic membranous nephropathy: diagnosis and treatment Clin J Am Soc Nephrol 3 905 919 10.2215/CJN.04321007 18235148
18. T Ehrenreich J Churg 1963 Pathology of membranous nephropathy Pathology Annals 3 145
19. JC Jennette SS Iskandar FG Dalldorf 1983 Pathologic differentiation between lupus and nonlupus membranous glomerulopathy Kidney Int 24 377 385 10.1038/ki.1983.170 1:STN:280:DyaL2c%2FmsFOjug%3D%3D 6358633
20. DC Cattran 2001 Idiopathic membranous glomerulonephritis Kidney Int 59 1983 1994 10.1046/j.1523-1755.2001.0590051983.x 1:STN:280:DC%2BD3MvitlahsA%3D%3D 11318974 (Pubitemid 32336818)
21. WG Couser M Nangaku 2006 Cellular and molecular biology of membranous nephropathy J Nephrol 19 699 705 1:CAS:528:DC%2BD2sXhtlyrtLjL 17173240
22. P Ronco H Debiec 2006 Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies J Am Soc Nephrol 17 1772 1774 10.1681/ASN.2006050497 1:CAS:528:DC%2BD28XntlantLg%3D 16775025 (Pubitemid 44036158)
23. P Ronco H Debiec 2005 Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization J Am Soc Nephrol 16 1205 1213 10.1681/ASN.2004121080 1:CAS:528:DC%2BD2MXksF2gs70%3D 15800120 (Pubitemid 41716505)
24. K Hirayama I Ebihara S Yamamoto H Kai K Muro K Yamagata M Kobayashi A Koyama 2002 Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis Nephron 91 255 261 10.1159/000058401 1:CAS:528:DC%2BD38XksVygtbc%3D 12053062 (Pubitemid 34621692)
25. M Nangaku SJ Shankland WG Couser 2005 Cellular response to injury in membranous nephropathy J Am Soc Nephrol 16 1195 1204 10.1681/ASN.2004121098 1:CAS:528:DC%2BD2MXksF2gs7w%3D 15800119 (Pubitemid 41716504)
26. MJ Penny RA Boyd BM Hall 1998 Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition J Am Soc Nephrol 9 2272 2282 1:CAS:528:DyaK1cXotVKnsrs%3D 9848781
27. SL Hogan KE Muller JC Jennette RJ Falk 1995 A review of therapeutic studies of idiopathic membranous glomerulopathy Am J Kidney Dis 25 862 875 10.1016/0272-6386(95)90568-5 1:STN:280:DyaK2M3ovFCjsg%3D%3D 7771482
28. BJ Laluck Jr DC Cattran 1999 Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy Am J Kidney Dis 33 1026 1032 10.1016/S0272-6386(99)70138-1 10352189
29. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group 2004 Idiopathic membranous nephropathy: definition and relevance of a partial remission Kidney Int 66 1199 1205 10.1111/j.1523-1755.2004.00873.x (Pubitemid 39121029)
30. DC Cattran Y Pei CM Greenwood C Ponticelli P Passerini E Honkanen 1997 Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications Kidney Int 51 901 907 10.1038/ki.1997.127 1:STN:280:DyaK2s3itVOltA%3D%3D 9067928
31. BE Marx M Marx 1999 Prediction in idiopathic membranous nephropathy Kidney Int 56 666 673 10.1046/j.1523-1755.1999.00598.x 1:STN:280: DyaK1Mzmt1Khsw%3D%3D 10432407 (Pubitemid 29353166)
32. F Ramirez BH Brouhard LB Travis EN Ellis 1982 Idiopathic membranous nephropathy in children J Pediatr 101 677 681 10.1016/S0022-3476(82)80289-8 1:STN:280:DyaL3s%2Fjt1ygtA%3D%3D 7131139 (Pubitemid 12006686)
33. P Latham S Poucell A Koresaar G Arbus R Baumal 1982 Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study J Pediatr 101 682 685 10.1016/S0022-3476(82)80290-4 1:STN:280:DyaL3s%2Fjt1ygtQ%3D%3D 7131140 (Pubitemid 12006687)
34. LJ Reichert RA Koene JF Wetzels 1998 Prognostic factors in idiopathic membranous nephropathy Am J Kidney Dis 31 1 11 10.1053/ajkd.1998.v31.pm9428445 1:STN:280:DyaK1c%2FovVOhsw%3D%3D 9428445
35. CL Abitbol J Chandar AM Onder O Nwobi B Montane G Zilleruelo 2006 Profiling proteinuria in pediatric patients Pediatr Nephrol 21 995 1002 10.1007/s00467-006-0103-9 16773413 (Pubitemid 43885100)
36. RT Gansevoort JE Heeg R Vriesendorp D de Zeeuw PE de Jong 1992 Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy Nephrol Dial Transplant 7 Suppl 1 91 96 1337189
37. S Sandhu N Wiebe LF Fried M Tonelli 2006 Statins for improving renal outcomes: a meta-analysis J Am Soc Nephrol 17 2006 2016 10.1681/ASN.2006010012 1:CAS:528:DC%2BD28Xntlanu78%3D 16762986 (Pubitemid 44036185)
38. SP Makker 2003 Treatment of membranous nephropathy in children Semin Nephrol 23 379 385 10.1016/S0270-9295(03)00054-8 1:CAS:528:DC%2BD3sXnsVynsbo%3D 12923726
39. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome (1979) A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301-1306
40. JS Cameron MJ Healy D Adu 1990 The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party Q J Med 74 133 156 1:STN:280:DyaK3c3msFyrsQ%3D%3D 2189149
41. DC Cattran T Delmore J Roscoe E Cole C Cardella R Charron S Ritchie 1989 A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy N Engl J Med 320 210 215 1:STN:280:DyaL1M%2FpslWhtA%3D%3D 2643046
42. Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G (2004) Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev (4):CD004293
43. C Ponticelli P Zucchelli P Passerini L Cagnoli B Cesana C Pozzi S Pasquali E Imbasciati C Grassi B Redaelli M Sasdelli F Locatelli 1989 A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy N Engl J Med 320 8 13 1:STN:280:DyaL1M%2Fot1Gqug%3D%3D 2642605
44. C Ponticelli P Altieri F Scolari P Passerini D Roccatello B Cesana P Melis B Valzorio M Sasdelli S Pasquali C Pozzi G Piccoli A Lupo S Segagni F Antonucci M Dugo SA MinariM L Pedrini G Pisano C Grassi M Farina R Bellazzi 1998 A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy J Am Soc Nephrol 9 444 450 1:CAS:528:DyaK1cXhvVegsro%3D 9513907
45. TF Imperiale S Goldfarb JS Berns 1995 Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials J Am Soc Nephrol 5 1553 1558 1:STN:280:DyaK2M3ns1WktA%3D%3D 7756587
46. DC Cattran GB Appel LA Hebert LG Hunsicker MA Pohl WE Hoy DR Maxwell CL Kunis North American Nephroltic Syndrome Study Group 2001 Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial Kidney Int 59 1484 1490 10.1046/j.1523-1755.2001.0590041484.x 1:CAS:528:DC%2BD3MXjtVOhtbs%3D 11260412 (Pubitemid 32281239)
47. M Praga V Barrio GF Juarez J Luno Grupo Espanol de Estudio de la Nefropatia Membranosa 2007 Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial Kidney Int 71 924 930 10.1038/sj.ki.5002215 1:CAS:528:DC%2BD2sXksFeksrk%3D 17377504 (Pubitemid 46663803)
48. G Miller R Zimmerman 3rd J Radhakrishnan G Appel 2000 Use of mycophenolate mofetil in resistant membranous nephropathy Am J Kidney Dis 36 250 256 10.1053/ajkd.2000.8968 1:CAS:528:DC%2BD3cXlvFCrsbo%3D 10922302
49. G Remuzzi C Chiurchiu M Abbate V Brusegan M Bontempelli P Ruggenenti 2002 Rituximab for idiopathic membranous nephropathy Lancet 360 923 924 10.1016/S0140-6736(02)11042-7 1:CAS:528:DC%2BD38Xnt1CqsrY%3D 12354476 (Pubitemid 35283838)
50. AS Bomback VK Derebail JG McGregor AV Kshirsagar RJ Falk PH Nachman 2009 Rituximab therapy for membranous nephropathy: a systematic review Clin J Am Soc Nephrol 4 734 74 10.2215/CJN.05231008 1:CAS:528:DC%2BD1MXltVyju7o%3D 19279120
51. BY Choy TM Chan KN Lai 2006 Recurrent glomerulonephritis after kidney transplantation Am J Transplant 6 2535 2542 10.1111/j.1600-6143.2006.01502.x 1:CAS:528:DC%2BD28Xht12isrbK 16939521 (Pubitemid 44571672)
52. P Kotanko CD Pusey JB Levy 1997 Recurrent glomerulonephritis following renal transplantation Transplantation 63 1045 1052 10.1097/00007890-199704270- 00001 1:STN:280:DyaK2s3nvVyrtA%3D%3D 9133463
53. M El Kossi A Harmer J Goodwin B Wagner J Shortland C Angel W McKane 2008 De novo membranous nephropathy associated with donor-specific alloantibody Clin Transplant 22 124 127 1:STN:280:DC%2BD1c%2FmsFWhtw%3D%3D 18217914
54. A Schwarz PH Krause G Offermann F Keller 1994 Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation Transplantation 58 650 654 1:STN:280:DyaK2M%2Fis12qtQ%3D%3D 7940683
55. R Habib C Kleinknecht MC Gubler 1973 Extramembranous glomerulonephritis in children: report of 50 cases J Pediatr 82 754 766 10.1016/S0022-3476(73) 80063-0 1:STN:280:DyaE3s7mt1Ghtw%3D%3D 4572936
56. EB Trainin H Boichis A Spitzer I Greifer 1976 Idiopathic membranous nephropathy. Clinical course in children N Y State J Med 76 357 360 1:STN:280:DyaE287ltVCqtQ%3D%3D 1062686
57. H Tsukahara Y Takahashi M Yoshimoto S Hayashi S Fujisawa F Suehiro K Akaishi Y Nomura K Morikawa M Sudo 1993 Clinical course and outcome of idiopathic membranous nephropathy in Japanese children Pediatr Nephrol 7 387 391 10.1007/BF00857546 1:STN:280:DyaK2c%2FgtFCjug%3D%3D 8398647